Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clingen Coagulation Factor Deficiency Variant Curation Expert Panel: Meeting the Need for Recommendations to Curate Variants in the Coagulation Factor Genes

Shruthi Mohan, PhD, Kristy Lee, MS, CGC, Manuel Carcao, Bhavya S Doshi, MD, Kate Downes, PhD, Geoff Kemball-Cook, PhD, Frank Leebeek, MD PhD, Jamie McCreery, MS, CGC, Connie H. Miller, PhD, Amanda B Payne, MPH,PhD, Valerie Trapp-Stamborski, PhD, Barbara A. Konkle, MD, Keith Gomez, MBBS, PhD MRCP, FRCPath

Blood (2019) 134 (Supplement_1): 5794.

https://doi.org/10.1182/blood-2019-124842

Published: 2019

Journal Articles

One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B

Steven Pipe, MD, Adam Giermasz, MD PhD, Giancarlo Castaman, MD, Nigel S. Key, MBChB, FRCP, Susan U Lattimore, Frank Leebeek, MD PhD, Wolfgang Miesbach, MD PhD, Michael Recht, MD PhD, Esteban Gomez, MD, Alison Long, Robert Gut, Annette von Drygalski, MD PharmD

Blood (2019) 134 (Supplement_1): 3348.

https://doi.org/10.1182/blood-2019-128765

Published: 2019

Journal Articles

Low ADAMTS13 Activity Is a Strong Risk Factor for Ischemic Stroke: A Prospective Cohort Study - the Rotterdam Study

Michelle Alida Helena Sonneveld, MD, Moniek de Maat, PhD, Marileen L.P. Portegies, MD, Albert Hofman, MD PhD, Peter L Turecek, PhD, Hanspeter Rottensteiner, PhD, Friedrich Scheiflinger, PhD, Peter J. Koudstaal, MD PhD, Mohammed A. Ikram, MD PhD, Frank Leebeek, MD PhD

Blood (2014) 124 (21): 113.

https://doi.org/10.1182/blood.V124.21.113.113

Published: 2014

Journal Articles

Microparticle-Associated Tissue Factor Activity and Venous Thrombosis in Multiple Myeloma.

Frank Leebeek, MD, PhD, Yuana Yuana, Suzanne Osanto, Moniek de Maat, Hajo Auwerda, Rogier Bertina, Pieter Sonneveld, MD, PhD

Blood (2008) 112 (11): 1812.

https://doi.org/10.1182/blood.V112.11.1812.1812

Published: 2008

Journal Articles

Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia?

Michiel Strijbos, MD, Precious Landburg, MD, Erfan Nur, MD, Bart J. Biemond, MD, PhD, Frank Leebeek, MD, PhD, Jan-Willem Gratama, PhD, Ashley Duits, PhD, John-John Schnog, MD, PhD

Blood (2008) 112 (11): 4798.

https://doi.org/10.1182/blood.V112.11.4798.4798

Published: 2008

NARROW

Clingen Coagulation Factor Deficiency Variant Curation Expert Panel: Meeting the Need for Recommendations to Curate Variants in the Coagulation Factor Genes

One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B

Low ADAMTS13 Activity Is a Strong Risk Factor for Ischemic Stroke: A Prospective Cohort Study - the Rotterdam Study

Microparticle-Associated Tissue Factor Activity and Venous Thrombosis in Multiple Myeloma.

Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia?

Email alerts

ASH Publications

American Society of Hematology

Clingen Coagulation Factor Deficiency Variant Curation Expert Panel: Meeting the Need for Recommendations to Curate Variants in the Coagulation Factor Genes

One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B

Low ADAMTS13 Activity Is a Strong Risk Factor for Ischemic Stroke: A Prospective Cohort Study - the Rotterdam Study

Microparticle-Associated Tissue Factor Activity and Venous Thrombosis in Multiple Myeloma.

Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only